These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14586600)

  • 21. A double-blind, placebo-controlled, dose-ranging safety evaluation of single-dose intravenous dolasetron in healthy male volunteers.
    Hunt TL; Cramer M; Shah A; Stewart W; Benedict CR; Hahne WF
    J Clin Pharmacol; 1995 Jul; 35(7):705-12. PubMed ID: 7560251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
    J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of Ondansetron on memory in schizophrenic patients.
    Levkovitz Y; Arnest G; Mendlovic S; Treves I; Fennig S
    Brain Res Bull; 2005 Apr; 65(4):291-5. PubMed ID: 15811593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist.
    Hui YF; Ignoffo RJ
    Cancer Pract; 1997; 5(5):324-8. PubMed ID: 9341357
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of infusion rate on the pharmacokinetics and tolerance of intravenous dolasetron mesylate.
    Dimmitt DC; Hunt TL; Spalitto AJ; Cramer MB; Shah AK; Arumugham T; Hahne W
    Ann Pharmacother; 1998 Jan; 32(1):39-44. PubMed ID: 9475818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of tendopathies with tropisetron.
    Stratz T; Varga B; Müller W
    Rheumatol Int; 2002 Nov; 22(6):219-21. PubMed ID: 12426658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
    Jones E; Koyama T; Ho RH; Kuttesch J; Shankar S; Whitlock JA; Cartwright J; Frangoul H
    Pediatr Blood Cancer; 2007 Mar; 48(3):330-2. PubMed ID: 16304666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of dolasetron following single- and multiple-dose intravenous administration to normal male subjects.
    Shah A; Lanman R; Bhargava V; Weir S; Hahne W
    Biopharm Drug Dispos; 1995 Apr; 16(3):177-89. PubMed ID: 7787130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.
    Pickering G; Loriot MA; Libert F; Eschalier A; Beaune P; Dubray C
    Clin Pharmacol Ther; 2006 Apr; 79(4):371-8. PubMed ID: 16580905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1.
    Dimmitt DC; Choo YS; Martin LA; Arumugham T; Hahne WF; Weir SJ
    Biopharm Drug Dispos; 1999 Jan; 20(1):29-39. PubMed ID: 10086835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis.
    Wingerchuk DM; Benarroch EE; O'Brien PC; Keegan BM; Lucchinetti CF; Noseworthy JH; Weinshenker BG; Rodriguez M
    Neurology; 2005 Apr; 64(7):1267-9. PubMed ID: 15824361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron.
    Dizdar V; Gilja OH; Hausken T
    Neurogastroenterol Motil; 2007 Dec; 19(12):977-82. PubMed ID: 17973637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
    Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A
    Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of the synthetic cannabinoid dronabinol on central pain in patients with multiple sclerosis--secondary publication].
    Svendsen KB; Jensen TS; Bach FW
    Ugeskr Laeger; 2005 Jun; 167(25-31):2772-4. PubMed ID: 16014264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.
    Johnson BA; Roache JD; Ait-Daoud N; Javors MA; Harrison JM; Elkashef A; Mojsiak J; Li SH; Bloch DA
    Drug Alcohol Depend; 2006 Oct; 84(3):256-63. PubMed ID: 16631323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
    Feys P; D'hooghe MB; Nagels G; Helsen WF
    Mult Scler; 2009 Mar; 15(3):371-8. PubMed ID: 19168602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
    Drossman DA; Danilewitz M; Naesdal J; Hwang C; Adler J; Silberg DG
    Am J Gastroenterol; 2008 Oct; 103(10):2562-9. PubMed ID: 18775020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
    Stankoff B; Waubant E; Confavreux C; Edan G; Debouverie M; Rumbach L; Moreau T; Pelletier J; Lubetzki C; Clanet M;
    Neurology; 2005 Apr; 64(7):1139-43. PubMed ID: 15824337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.